What are the common causes of bacteremia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 26, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Common Causes of Bacteremia

The most common causes of bacteremia are Escherichia coli (accounting for approximately 36-42% of cases), followed by Staphylococcus aureus (9-23%), coagulase-negative staphylococci (17%), and Streptococcus pneumoniae (12-13%), with the specific distribution varying by patient population and clinical setting. 1, 2, 3, 4

Primary Causative Organisms by Clinical Context

Community-Acquired Bacteremia in General Population

The predominant pathogens in community-acquired bacteremia include:

  • E. coli is the single most common pathogen, representing 36% of all community-acquired bacteremia cases 1
  • S. pneumoniae accounts for 13% of cases and is a leading cause of bacteremia-associated mortality 1, 5
  • S. aureus causes approximately 9.5% of cases and has particularly high mortality rates (15-30% case fatality) 1, 4
  • Salmonella enteritidis (2.9%), Pseudomonas aeruginosa (2.7%), Proteus mirabilis (2.7%), and Neisseria meningitidis (2.5%) represent less common but clinically significant causes 1

Febrile Infants (≤90 Days Old)

In previously healthy febrile infants admitted to general care units:

  • E. coli is the most common pathogen, accounting for 42% of bacteremia cases 3
  • Group B Streptococcus follows at 23% of cases 3
  • S. pneumoniae is more likely in older infants within this age range 3
  • Listeria monocytogenes is notably absent in contemporary series, questioning the need for empirical coverage 3

Neutropenic and Immunocompromised Patients

In patients with hematological malignancies and chemotherapy-induced neutropenia:

  • Coagulase-negative staphylococci represent 17% of cases, though they are weak pathogens rarely causing rapid deterioration 6, 2
  • E. coli remains prominent at 16% 2, 7
  • Alpha-hemolytic streptococci account for 12% 2
  • S. aureus causes 9% of cases 2
  • Klebsiella species represent 9% 2, 7
  • Enterococcus species account for 7%, with E. faecium showing increasing incidence and higher mortality 2
  • Pseudomonas species cause 5% of cases but carry significantly higher mortality rates 2, 7

Among gram-negative organisms in neutropenic patients, P. aeruginosa almost invariably progresses to bacteremia when profound neutropenia develops, while E. coli and K. pneumoniae lead to bacteremia in only a moderate proportion of colonized patients 7

Catheter-Related Bacteremia

When central venous catheters are present, specific organisms are particularly associated with catheter-related infection:

  • S. aureus bacteremia has a >92% likelihood of being catheter-related when a CVC is in place 8
  • Coagulase-negative staphylococci are strongly associated with CVC infection 8
  • Corynebacterium (especially JK-1), Bacillus species, and Candida species are particularly linked to catheter-related bacteremia 8

Overall, 73% of bacteremias in patients with CVCs are related to the catheter as the source 8

Temporal Trends and Resistance Patterns

Changing Epidemiology

  • The balance between gram-negative and gram-positive organisms has remained relatively stable over extended periods in settings without antibacterial prophylaxis 2
  • E. faecium bacteremia has shown significant increases in incidence 2
  • Coagulase-negative staphylococci proportions have decreased while Enterococcus species have increased 1

Antimicrobial Resistance

  • Fluoroquinolone resistance in E. coli increased dramatically from 3.5% in 1995 to 14.4% in 2000 1
  • Extended-spectrum beta-lactamase (ESBL) genes confer broad β-lactam resistance, primarily among Klebsiella species and E. coli 6
  • Carbapenemase-producing organisms, including Klebsiella species and P. aeruginosa, may be refractory to carbapenems 6
  • Organisms producing Klebsiella pneumoniae carbapenemases (KPCs) are resistant to all β-lactam antibiotics and may require colistin or tigecycline 6

Clinical Pitfalls and Considerations

A critical caveat: Single blood cultures positive for coagulase-negative staphylococci should generally be dismissed as contaminants if subsequent cultures are negative 6. However, polymicrobial bacteremia occurs in approximately 6% of cases and should not be automatically dismissed 1.

Risk stratification matters: Non-low-risk bacteremic infants are more likely to have E. coli or group B Streptococcus than low-risk bacteremic infants 3. In hospitalized patients, bacteremia incidence is highest on the day of admission and declines rapidly to Day 3-7, then increases steadily until Day 12 9.

References

Research

[Community-acquired bacteremia].

Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia, 2001

Research

Gram-negative bacteremia.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 1993

Guideline

diagnosis of infection in sepsis.

Intensive Care Medicine, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.